Stock Market Today: Hims & Hers Tumbles 12% on Revenue Miss Despite 73% Growth

Hims & Hers Health Inc. (NYSE: HIMS) fell 12.36% to $55.52, with volume spiking to nearly 104 million shares--more than twice its three-month average. The stock now trades nearly 24% below its recent high, despite growing second-quarter revenue 73% year over year to $544.8 million. That figure fell just short of analyst expectations, triggering a sharp sell-off.

The company posted net income of $42.5 million, beating forecasts, and more than doubled adjusted EBITDA to $82.2 million. Subscribers rose 31% to 2.4 million, and average monthly revenue per user grew 30% to $74.

Peers were mixed: Teladoc Health (NYSE: TDOC) edged down 0.14%, while Option Care Health (NASDAQ: OPCH) fell 0.6%. Investors showed relative caution across digital health, though Hims' premium valuation at a P/E of 81 and negative free cash flow appeared to amplify downside pressure.

Despite the drop, management reaffirmed full-year guidance and highlighted future expansion into hormone health, diagnostics, and longevity services. Some analysts remain optimistic, though the quarter may test short-term confidence.

Market data sourced from Google Finance and Yahoo! Finance on Tuesday, August 5, 2025.

Should you invest $1,000 in Hims & Hers Health right now?

Before you buy stock in Hims & Hers Health, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,103,313!*

Now, it’s worth noting Stock Advisor’s total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of August 4, 2025

Daily Stock News has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Hims & Hers Health and Teladoc Health. The Motley Fool has a disclosure policy.